The U.S. Department of Health and Human Services (HHS) has issued a final rule that requires covered entities—including many health plans—to update their Notice of Privacy Practices (Privacy Notice). This change enhances privacy protections for highly sensitive Substance Use Disorder (SUD) treatment records. Why the Update is Necessary The HIPAA Privacy Rule already mandates that … Continued
The HIPAA Privacy Rule generally requires covered entities—such as health plans, health care providers, and health care clearinghouses—to give individuals a Notice of Privacy Practices (Privacy Notice). This notice explains how their protected health information (PHI) may be used or shared and outlines their rights related to PHI. In April 2024, the U.S. Department of Health and … Continued
Key Takeaways From the CAA-mandated Prescription Drug Cost Report The Consolidated Appropriations Act, 2021 (CAA) mandates that group health plans and health insurance issuers submit annual data on premiums, enrollment, medical spending and prescription drug rebates to various departments to address this. This initiative, known as the Prescription Drug Data Collection (RxDC), aims to enhance … Continued
One Huntington Quadrangle
Suite 4N10
Melville, NY 11747
Phone: (631) 465.0606
Email: info@jmbrassillgroup.com
